Quarterly report · Q2
3154.TEDINET S100SS0C
Period2023-07-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥126.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥239.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥118.3bn | 2022-07-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥681m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2022-07-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥900m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2022-07-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥895m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.4bn | 2022-07-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥859m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥859m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥112.6bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥97.5bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥99.5bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥94.0bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥78.9bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥18.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.5bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2022-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥3.3bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥863m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥291m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥863m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.5bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥23.03 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.78 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.32 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.19 | 2022-07-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.8 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.93 | 2023-07-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥68.09 | 2022-07-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥39.07 | 2022-07-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 16.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥4.2bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥4.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥201m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-12-31 | −¥81,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-12-31 | −¥81,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-12-31 | −¥3.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥115.6bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥115.6bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥81,000 |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥197m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-12-31 | ¥118.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-12-31 | ¥118.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥81,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-12-31 | ¥4.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 550
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 115583589000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember | 2720819000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 118304409000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 118304409000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 81000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 81000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -81000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 115583671000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember | 2720819000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 118304490000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -81000 | JPY |
| Net sales | Prior1YTDDuration | 118304409000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 4570965000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember | 196621000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 4767586000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -3670245000 | JPY |
| Operating income | Prior1YTDDuration | 1097341000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 123824905000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember | 2888150000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 126713055000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 126713055000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 6924000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 6924000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -6924000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 123831829000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember | 2888150000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 126719979000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -6924000 | JPY |
| Net sales | CurrentYTDDuration | 126713055000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 4631679000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember | 200521000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 4832200000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -4151427000 | JPY |
| Operating income | CurrentYTDDuration | 680772000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-02-09 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第15期第２四半期(自 2023年10月１日 至 2023年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)メディアスホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | MEDIUS HOLDINGS Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 池 谷 保 彦 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区有楽町一丁目２番２号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-6811-2958(代表) |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |